Purus Wealth Management, LLC Bio N Tech Se Transaction History

Purus Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$126.25 - $231.85 $823,023 - $1.51 Million	-6,519 Closed	0 $0
Q4 2021 Jan 19, 2022	SELL	$216.64 - $362.52 $306,328 - $512,603	-1,414 Reduced 17.82%	6,519 $1.68 Million
Q3 2021 Oct 14, 2021	SELL	$205.93 - $447.23 $26,770 - $58,139	-130 Reduced 1.61%	7,933 $2.17 Million
Q2 2021 Jul 22, 2021	SELL	$113.32 - $241.49 $32,522 - $69,307	-287 Reduced 3.44%	8,063 $1.81 Million
Q1 2021 May 12, 2021	BUY	$85.73 - $119.5 $451,368 - $629,167	5,265 Added 170.66%	8,350 $912,000

Q4 2020 Feb 23, 2021	BUY	$72.71 - $129.54 $224,310 - $399,630	3,085 New	3,085 $251,000

327

40.4M

1.31M

1.37M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Purus Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Purus Wealth Management, LLC with notifications on news.